VC Split Rock backs off of med tech investing

Venture capital outfit Split Rock Partners is planning to abandon the medical device industry, Forbes reports, looking to ditch healthcare investments and refocus on Internet services. The generalist investor has long diversified its bets across the technology space, but Managing Director Michael Gorman told Forbes that the challenging market for med tech has made the sector less attractive. Split Rock's healthcare portfolio includes Ardian, Santarus and Twelve. Article